Events

The Loulou Foundation invites Dr. Kammerman to speak at the 2019 CDKL5 Forum

Cambridge, Massachusetts, USA

Invited speaker and biostatistics regulatory consultant at the CDKL5 Forum Annual Meeting, presenting on how to design clinical studies for small populations.

Dr. Kammerman appointed to the External Technical Advisory Committee, Northwestern University Clinical Outcomes Assessment Team (NUCOAT)

Chicago, Illinois, USA

Serving as regulatory statistics and clinical outcome assessment consultant. NUCOAT, led by David Cella, is developing core physical function outcome sets with support from a CDER pilot grant.

2019 DIA/FDA Biostatistics Industry and Regulator Forum

North Bethesda, Maryland, USA

Dr. Kammerman attended the forum and has written a summary of the sessions.

DIA names Dr. Kammerman an Associate Editor of the Therapeutic Innovation & Regulatory Science (TIRS) Journal

Appointed Associate Editor of the DIA’s TIRS journal.

Longitudinal Modeling Approaches to Assess the Association Between Changes in 2 Clinical Outcome Assessments

Webinar · DIA STAT Virtual Journal Club

Dr. Kammerman served as discussant.

Advancing Endpoint Development for Preterm Neonates with Pulmonary Morbidities

Washington, DC · Duke-Margolis Center for Health Policy

Invited endpoints expert.

Advancing the Science of Study Endpoints: Endpoint Evolution During Drug Development – Time to Deterioration Endpoint Case Study

North Bethesda, Maryland · Drug Information Association

Invited speaker and panel discussant.